{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:34:57Z","timestamp":1793738097481,"version":"4.6.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jns.2020.116799","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T11:54:42Z","timestamp":1585050882000},"page":"116799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Efficacy and tolerability of intravenous brivaracetam for status epilepticus: A systematic review"],"prefix":"10.1016","volume":"413","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-1822","authenticated-orcid":false,"given":"Kevin Michael C.","family":"Moalong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian I.","family":"Espiritu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Laurence L.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.116799_bb0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2013 report of the ILAE task force on classification of status epilepticus comment: historical","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2020.116799_bb0010","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/CON.0000000000000225","article-title":"Status epilepticus","volume":"21","author":"Hocker","year":"2015","journal-title":"Continuum (Minneap. Minn)"},{"key":"10.1016\/j.jns.2020.116799_bb0015","first-page":"1","article-title":"Status epilepticus in adults","volume":"4422","author":"Betjemann","year":"2015","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jns.2020.116799_bb0020","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.116799_bb0025","first-page":"1","article-title":"Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes","author":"Leitinger","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2020.116799_bb0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/17512433.2016.1156529","article-title":"Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus","volume":"9","author":"Strzelczyk","year":"2016","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2020.116799_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756285617742081","article-title":"Brivaracetam: a novel antiepileptic drug for focal-onset seizures","volume":"11","author":"Stephen","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jns.2020.116799_bb0040","first-page":"1","article-title":"A review of the pharmacology and clinical efficacy of brivaracetam","volume":"10","author":"Klein","year":"2018","journal-title":"Clin. Pharmacol. Adv. Appl."},{"key":"10.1016\/j.jns.2020.116799_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/epi.13267","article-title":"Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action","volume":"57","author":"Nicolas","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2020.116799_bb0050","first-page":"1","article-title":"Rescue therapies for seizure emergencies: new modes of administration","volume":"2018","author":"Maglalang","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2020.116799_bb0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/1756285616665564","article-title":"Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base","volume":"9","author":"Brandt","year":"2016","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jns.2020.116799_bb0060","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/epi.13787","article-title":"Acute and long-term effects of brivaracetam and brivaracetam \u2013 diazepam combinations in an experimental model of status epilepticus","volume":"58","author":"Niquet","year":"2017","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2020.116799_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.seizure.2016.11.008","article-title":"The adverse event profile of brivaracetam: a meta-analysis of randomized controlled trials","volume":"45","author":"Li-na","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.jns.2020.116799_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jns.2020.116799_bb0075","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","article-title":"Salzburg consensus criteria for non-convulsive status epilepticus - approach to clinical application","volume":"49","author":"Leitinger","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jns.2020.116799_bb0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/epi.14486","article-title":"Intravenous brivaracetam in status epilepticus: a retrospective single-center study","volume":"59","author":"Kalss","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2020.116799_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yebeh.2017.03.028","article-title":"Treatment of refractory and super-refractory status epilepticus with brivaracetam: a cohort study from two German university hospitals","volume":"70","author":"Strzelczyk","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jns.2020.116799_bb0090","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/epi.14476","article-title":"Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus","volume":"59","author":"Strzelczyk","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2020.116799_bb0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eplepsyres.2018.12.001","article-title":"Intravenous brivaracetam in status epilepticus: correlation between loading dose, plasma levels and clinical response","volume":"149","author":"Aicua-Rapun","year":"2019","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jns.2020.116799_bb0100","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/epi.16094","article-title":"Use of intravenous brivaracetam in status epilepticus: a multicenter registry","volume":"60","author":"Santamarina","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2020.116799_bb0105","first-page":"1","article-title":"Brivaracetam in status epilepticus: a systematic review","volume":"1","author":"Esmail","year":"2019","journal-title":"Neurol. Res. Surg."},{"key":"10.1016\/j.jns.2020.116799_bb0110","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.030","article-title":"The Rankin focused assessment \u2014 ambulation: a method to score the modified Rankin scale with emphasis on walking ability","volume":"25","author":"Patel","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2020.116799_bb0115","first-page":"477","article-title":"The Glasgow outcome scale - 40 years of application and refinement","volume":"12","author":"Mcmillan","year":"2016","journal-title":"Nat. Publ. Gr."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:52:08Z","timestamp":1758383528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20301350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":23,"alternative-id":["S0022510X20301350"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116799","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerability of intravenous brivaracetam for status epilepticus: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116799"}}